| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |